|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02480 LUZHU BIOTECH-B
Nominal 
23.100 +0.080 (+0.348%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 0 | -- | 0 | 0 | 0 |
| Cost of Sales | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (551,546) | (441,077) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | (26,459) | (21,542) | (3,126) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (168,235) | -32.531% | (249,350) | (725,180) | (539,357) | |
| Taxation | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (168,235) | -32.531% | (249,350) | (725,180) | (539,357) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (2,076) | -59.806% | (5,165) | 473 | 562 |
| Depreciation & Amortisation | 25,010 | 55.264% | 16,108 | 9,884 | 6,542 |
| Directors' Emoluments | 16,814 | -58.531% | 40,546 | 78,637 | 46,294 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -83.000 | -33.600% | -125.000 | -498.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.427) | -- | (0.955) | (0.531) | -- |
| NBV per share ($) | 4.247 | -- | 5.041 | -- | -- |
| Remarks: | Real time quote last updated: 15/12/2025 14:27 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -77,570 |
| %Change | -29.442% |
| EPS / (LPS) | RMB -0.390 |
| NBV Per Share (¥) | RMB 3.710 |